Dlk (also termed ZIP kinase) is a novel serine/threonine kinase with a unique C-terminal domain that is rich in arginine and contains three putative NLS motifs and a functional lecuine zipper. Dlk is indeed localized in the nucleus where it shows a speckled distribution. To elucidate the biological functions of Dlk, we wanted to identify the signals relevant for nuclear transport and further the nuclear structures which Dlk binds to. Expression of various deletion and point mutations of Dlk as GFP fusion proteins revealed that the leucine zipper is required for association with speckles and the most C-terminal NLS is necessary and sucient for nuclear transport. Interestingly, a C-terminal deletion mutant defective for nuclear transport exhibited a pronounced colocalization with actin ®laments and, even more strikingly, was a very potent inducer of apoptosis. This apoptotic activity was abrogated, however, when this mutant was retargeted to the nucleus via a heterologous NLS from large T, indicating that Dlk only exerts an apoptotic activity in the cytoplasm. To identify the speckle like structures to which Dlk binds we performed immuno¯uorescence analyses with antibodies directed against representative marker proteins of replication, transcription, or splicing centers. None of these marker proteins revealed a colocalization with Dlk. Instead, we found a partial colocalization with PML bodies which seem to play a key role in regulation of apoptosis. Taken together, these data strongly suggest a functional role for Dlk in control of cell survival which is dependent on its subcellular localization.
Introduction
Apoptosis is an evolutionarily conserved and highly organized form of cell death. It plays a crucial role in development and tissue homeostasis and protects organisms from pathogenesis of a variety of diseases including cancer, autoimmune disease, neurodegenerative disorders and viral infection. In recent years a steadily increasing number of genes involved in apoptosis have been identi®ed. Apoptosis can be triggered either by external activators such as fas ligand, TNFa etc., binding to their receptors at the cell surface, or by internal signals like DNA damage, reactive oxygen species, etc. arising within the cell. The decision whether an individual cell will live or die is regulated by the balance of (i) cell death and survival signals which are transduced via various intracellular signalling pathways and (ii) of proapoptotic and antiapoptotic proteins, like the members of the bcl family, that regulate the onset of apoptosis via activation of caspases and nucleases leading to the degradation of speci®c target proteins and chromatin and ®nally to cell death (for recent reviews see Green, 1998 and Dragovich et al., 1998) .
Recently, protein kinases have been implicated in various apoptotic and antiapoptotic pathways (Jarpe et al., 1998) . For example, in the JNK pathway, ASK1, MEKK1 and JNK itself function as positive mediators of apoptosis (Ichijo et al., 1997; Xia et al., 1995; Johnson et al., 1996) . Other kinases which can modulate the apoptotic response are RIP, PKC d, PITSLRE and DAP kinase (Stanger et al., 1995; Emoto et al., 1995; Lathi et al., 1995; Deiss et al., 1995) . Kinases involved in antiapoptotic pathways include PI3K and its downstream target Akt (Yao and Cooper, 1995; Franke et al., 1997) , NF-kB activators NIK, IKK a and b (Regnier et al., 1997; Zandi et al., 1997) , ERKs (Xia et al., 1995) and Raf (Wang et al., 1996) . Dlk (for DAP like kinase) (KoÈ gel et al., 1998) , also known as ZIP kinase (Kawai et al., 1998) , is a novel serine/threonine kinase with high homology to the kinase domain of DAP (death associated protein) kinase, a mediator of g-interferon-induced apoptosis (Cohen et al., 1997) . However, both kinases dier completely in their extra-kinase domains, their subcellular localization, and their apoptotic activities. DAP kinase contains a Ca/calmodulin binding region, an ankyrin repeat region, a region required for the interaction with the cytoskeleton, and a death domain. Dlk, on the other hand, contains an arginine-rich Cterminal domain, embodying three putative nuclear localization signals (NLSs), and a functional leucine zipper, therefore the term ZIP kinase (Kawai et al., 1998) . DAP kinase was shown to be colocalized with actin ®laments, whereas Dlk is targeted to the nucleus where it exhibits a diuse as well as punctuate distribution (KoÈ gel et al., 1998) . Moreover, DAP kinase induces apoptosis upon ectopic expression, whereas Dlk does not induce apoptosis to a significant extent, at least not in REF52.2 rat ®broblasts (KoÈ gel et al., 1998) . This latter ®nding is at variance with ®ndings by Kawai et al. (1998) , who reported that ZIP kinase, the murine homolog of Dlk, induces apoptosis in NIH3T3 cells. In the following paper, we will keep the term Dlk and will use Dlk/ZIP kinase in the more general discussion.
In the present study we set out (1) to identify the functional NLSs of Dlk; (2) the nuclear domains to which Dlk colocalizes and (3) to explore the biological activities of Dlk. Our data demonstrate that the most C-terminal NLS is both necessary and sucient for nuclear transport of Dlk. Furthermore, we demonstrate that Dlk partially colocalizes with PML bodies which are involved in the regulation of apoptosis. Strikingly, C-terminal truncation of Dlk not only impairs its nuclear transport but leads to a pronounced colocalization with actin ®laments and to ecient induction of apoptosis. These data imply a functional role for Dlk in the control of cell survival which depends on its subcellular localization.
Results

Subcellular localization of various Dlk deletion mutants
In order to study the subcellular targeting of Dlk we generated a series of deletion mutants of Dlk and fused them to the coding sequence of GFP (green¯uorescent protein). These mutants were designed to sequentially delete from the C-terminus the leucine zipper or two or three of the putative NLS motifs (see Figure 1) . Thus, mutant DC1 lacks the leucine zipper motif but retains all four putative NLSs; mutant DC2 additionally lacks part of the arginine-rich domain including putative NLSs 3 and 4; mutant DC3 lacks the entire extrakinase domain including NLS 2. An N-terminal deletion mutant (DN1) lacking the kinase domain but comprising the complete extra-kinase domain was generated to complement the C-terminal truncation mutants. Kinase-negative mutants carrying an exchange of Lys42 for Ala in the ATP binding site (see Materials and methods) were also generated to see whether the observed eects might be kinase-dependent. Figure 1 summarizes all mutants employed in this study. All GFP-Dlk fusion proteins encompassing the kinase domain (except for the K42A mutants, of course) were tested positive in a kinase assay with myosin light chain as substrate (data not shown).
Expression constructs were transfected into REF52.2 cells and inspected by¯uorescence microscopy 24 h later. Expression of full length wild-type Dlk revealed that in the vast majority of the transfected cells GFP-Dlk was localized exclusively in the nucleus (Figure 2a ). About 70% of these cells exhibited a speckled uorescence in a diuse background, in agreement with previous observations (KoÈ gel et al., 1998) . The number of speckles varied from only a few to over 100 per cell. In a minor fraction of transfected cells, Dlk was also found in the perinuclear region or distributed over the entire cell (see Figure 5a , for example). The observed speckled distribution pattern of GFP-Dlk was not an artefact of the GFP expression system, since the localization of HAtagged Dlk was identical to that of GFP-Dlk (data not shown) and GFP alone exhibited only a diuse distribution over the entire cell (Figure 2b ). To test whether nuclear localization of Dlk was in¯uenced by its intrinsic kinase activity, a kinasenegative mutant K42A was employed. This mutant was eciently transported into the nucleus but association with speckles was strongly reduced (data not shown). A similar phenotype was seen with mutant DC1 lacking the leucine zipper, shown in Figure 2c . Nuclear transport of DC1 was unaected but association with speckles was greatly reduced (in less than 5% of the cells). These data indicated that association of Dlk with these structures was speci®c and dependent on its kinase activity and its leucine zipper.
Mutant DC2 did no longer accumulate in the nucleus, rather it appeared to be distributed over the entire cell or even excluded from the nucleus ( Figure  2d ) suggesting that active nuclear transport of this mutant was impaired due to deletion of the relevant NLS (NLS 3 and/or 4). In agreement with this assumption, mutant DN1, containing NLSs 2 ± 4 exhibited an exclusive nuclear localization, without a speckle-type¯uorescence pattern, however, as shown in Figure 2e . Moreover, providing mutant DC2 with a heterologous NLS of SV40 large T antigen (DC2 LT-NLS) resulted in ecient nuclear accumulation, as demonstrated in Figure 2f . The fraction of mutant DC2 found in the nucleus might be transported through putative NLS 1, which is located in the kinase domain (see Discussion).
The above data indicated that either NLS 3 or NLS 4, or both are critical for ecient nuclear transport of Dlk. For further studies we generated two additional mutants. In mutant RR341/342AA two arginines in NLS 3 were mutated to alanine and in mutant RR406/ 407AL two arginines in NLS 4 were exchanged to alanine and leucine, respectively (see Figure 1 ). Mutant RR341/342AA exhibited a normal nuclear localization indistinguishable from that of wild-type Dlk ( Figure  2g ). In contrast, mutant RR406/407AL was clearly excluded from the nucleus. Instead, this mutant aggregated in the perinuclear area in most cells ( Figure 2h ). These results indicate that NLS 4 is the functional NLS of Dlk. Thus, the other putative NLSs 1 ± 3 that are present in mutant RR406/407AL are either irrelevant or inaccessible for the nuclear translocation machinery.
Dlk colocalizes with PML bodies but not with other known nuclear domains
The speckle-type distribution and the phosphorylation of core histones in vitro (KoÈ gel et al., 1998) suggested a role of Dlk in regulation of transcription, splicing, or replication. To investigate the identity of the speckled domains with which full length Dlk associates we employed a panel of antibodies directed against representative marker proteins, which have been shown to exhibit punctate staining patterns, and examined a possible colocalization with Dlk by immuno¯uorescence microscopy. Antibodies directed against RNA polymerase II (transcription centers; Wansink et al., 1993) , SC35 and U5-116 kD (both located in splicing centers; Spector et al., 1991; Fabrizi et al., 1997) , or against PCNA (located in replication factories; Hozak et al., 1994) , all revealed staining patterns distinct from Dlk (data not shown). However, when we tested antibodies against PML, which is localized in socalled nuclear bodies (Dyck et al., 1994) , we found a considerable overlap with Dlk (compare Figure 3a ± c). The colocalization of Dlk and PML was only partial, however. In nuclei with few PML bodies (less than ten) both proteins showed a high degree of colocalization (arrow in Figure 3 ), whereas in nuclei with a large number of PML bodies the proportion of double positive signals per nucleus was generally lower. This ®nding might shed some light onto the biological function of Dlk, since PML bodies seem to play a key role in the control of cell survival (Quignon et al., 1998; Wang et al., 1988) .
Mutant DC2 is associated with actin ®laments As shown above, mutant DC2 did no longer accumulate in the nucleus, rather it appeared to be distributed over the entire cell. In some cases, however, a ®lamentous staining pattern was seen. To analyse whether any of the mutants colocalize with de®ned extranuclear structures, the transfected cells were ®xed and permeabilized with Triton X-100 to remove the soluble fraction of overexpressed Dlk which might obscure an association with speci®c cellular structures. Surprisingly, the detergent-insoluble fraction of mutant
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Figure 3 Colocalization of Dlk with PML bodies. REF52.2 cells were transfected with Dlk wt, ®xed and prepared for immuno¯uorescence analysis with anti-PML antibody and Cy3-conjugated secondary antibody as described in Materials and methods. (a) shows the green¯uorescence (GFP) with a typical speckled distribution of Dlk wt in the nucleus whereas (b) shows the staining pattern of PML. In the case of the overlay of both Dlk and PML (c) green and red signals (no colocalization) were subtracted to selectively retain yellow signals (indicating coincident green and red signals). The arrow points to a nucleus with complete matching of Dlk and PML. Scale bar, 10 mm DC2 exhibited a pronounced association with cytoskeletal structures reminiscent of actin ®bres (Figure 4a ). This interpretation was con®rmed by actin-speci®c staining with TRITC-conjugated phalloidin giving rise to a staining pattern very similar to that of GFP-DC2 with sparing of the nuclei, however (see Figure 4b for actin staining and Figure 4c for the merged pattern), thus strongly suggesting a colocalization of DC2 with actin ®laments. This interpretation was further con®rmed by treating DC2-transfected cells with cytochalasin B leading to disruption of both the actin ®laments and the DC2-associated structure (data not shown). The DAPI staining of the same cells in Figure  4d shows that some nuclei are deformed indicating that these cells will eventually undergo apoptosis later on. Very similar results were obtained with mutant DC3 (data not shown). Interestingly, full length Dlk, when aberrantly located in the cytoplasm or the nuclear transport defective point mutant RR407/407AL did not exhibit any colocalization with actin ®bres (data not shown) suggesting that the domain responsible for this interaction might be hidden in the full-length protein. Moreover, the kinase negative version of mutant DC2 (K42ADC2) did not interact with actin ®laments either (data not shown, see the even distribution in Figure 5e ). The latter result indicates that this interaction is dependent on the kinase activity and argues against the possibility of ®xation artefacts.
C-terminal deletion mutants of Dlk induce apoptosis
In our experimental system, wild-type Dlk did not induce apoptosis to a signi®cant extent (about 10% above the background seen with GFP expression plasmid; KoÈ gel et al., 1998; see Figure 6) . Surprisingly, the C-terminal deletion mutants DC2 and DC3 induced apoptosis with high eciency. About 80% of cells expressing DC2 and 60% of cells expressing DC3 showed typical morphological signs of apoptosis, as judged from the appearance of extensive membrane blebbing (shown for mutant DC2 in Figure 5c ), and chromatin condensation and nuclear fragmentation, as revealed by DAPI staining (Figure 5d ). To investigate whether this apoptotic activity was dependent on the kinase activity we employed the respective kinase negative deletion mutants K42ADC2 and K42ADC3. These mutants induced only background levels of apoptosis (Figure 5e ,f, see Figure 6 for quantitation). Please notice that the apoptotic activity of the full length K42A mutant was also reduced to background levels ( Figure 6 ). The apoptotic activity of the C-terminal deletion mutants could be due to the truncation per se, perhaps by releasing an inhibitory domain, or due to aberrant localization in the cytoplasm. To test this latter possibility, mutant DC2LT-NLS, which due to its heterologous NLS was eciently translocated to the nucleus (Figure 2f ) was employed. This mutant was devoid of any apoptotic activity thus indicating that the high apoptotic potential of mutant DC2 was dependent on its cytoplasmic localization. This conclusion is further supported by the ®nding that the small fraction of wild-type Dlk-expressing cells that entered apoptosis, always exhibited cytoplasmic localization of Dlk. An example is shown in Figure 5a , b. The data on apoptosis are summarized in Figure 6 . Kawai et al. (1998) reported that ZIP kinase, the murine homologue of Dlk, induces apoptosis in NIH3T3 cells. To investigate whether our results apply for NIH3T3 cells too, we repeated some key experiments with these cells, with essentially the same outcome, that is low apoptotic activity of wt Dlk and high activity of mutants DC2 and DC3. Thus, the discrepancy between the results of Kawai et al. (1998) and ours does not seem to be due to cell type speci®city. Rather, it may be due to other dierences between our experimental systems such as dierent levels of Dlk/ZIP kinase, concentrations of growth or survival factors in the growth medium, etc.
Discussion
Identi®cation of the nuclear localization signal
In this study we investigated the subcellular targeting of Dlk and its potential involvement in apoptotic pathways. Deletion and site directed mutagenesis identi®ed NLS 4 with the sequence L 404 KRRLCRL as the relevant NLS that is both necessary and sucient for nuclear transport since point mutations in this sequence led to nuclear exclusion. However, this applies only for full length Dlk. Deletion mutants DC2 and DC3 were both impaired in nuclear transport and distributed throughout the entire cell. But a substantial fraction of these mutants still entered the nucleus, as reported for a corresponding mutant of ZIP kinase (Kawai et al., 1998) . We assume that nuclear transport of these mutant proteins is facilitated by the remaining putative NLS 1 located in the kinase domain. This putative NLS with the sequence I 44 KKRRLP is partially conserved between Dlk and DAP kinase and has been shown to direct nuclear transport of DAP kinase, but only upon deletion of the C-terminal extra-kinase domain (Cohen et al., 1997) , whereas full length DAP kinase is retained in the cytoplasm suggesting that this NLS motif is inaccessible in the full length protein. This interpretation might also apply for Dlk.
Colocalization of Dlk with nuclear bodies
Immuno¯uorescence analyses with antibodies against transcription, splicing or replication factors, all of which exhibited a speckled distribution (data not shown; for references see Results section), did not reveal any colocalization with Dlk. This was somewhat surprising since the interaction with transcription factors such as ATF-4 (Kawai et al., 1998 ; see also Page et al., 1999) , implies a role of Dlk in transcription. Also, the ®nding that association with speckles requires the leucine zipper suggests an interaction with transcription factors. However, the staining patterns of RNA polymerase II or splicing factors are rather complex and a partial overlap with Dlk speckles cannot be excluded.
On the other hand, we found a considerable overlap of Dlk speckles with PML bodies. PML bodies represent assemblies of 20 or more dierent proteins, including Rb, CBP and the proapoptotic gene products bax and p27 the latter two of which seem to be recruited to PML bodies by the PML protein (Quignon et al., 1998) . The PML gene has recently been shown to play a key role in the control of cell death and survival. Homozygous deletion of PML renders cells resistant to various apoptotic stimuli including DNA damage, TNFa, IFNs, anti-fas and ceramide suggesting that PML may serve as an integrator of multiple apoptotic pathways (Wang et al., 1998) . Additionally, PML bodies have been found associated with CBP and nascent RNA suggesting a role in transcription (LaMorte et al., 1998) . Thus, the interaction of Dlk with PML assemblies could be related to transcription or apoptosis or both. That colocalization of Dlk with PML bodies was only partial is not too surprising. PML-associated proteins display considerable heterogenieity with respect to association with particular PML bodies (Bloch et al., 1999) . Clearly, this issue requires further investigation.
Colocalization of truncation mutants with actin ®laments
Surprisingly, the deletion mutants DC2 and DC3 were associated with the actin cytoskeleton, a property shared with DAP kinase (Cohen et al., 1997) . Colocalization was dependent on the kinase activity of the Dlk mutants suggesting that either autophosphorylation of Dlk itself or phosphorylation of the target proteins is required for this interaction. This association with actin ®laments may be related to membrane blebbing, an early event in apoptotic processes that can be induced by phosphorylation of MLC (Mills et al., 1998) . Indeed, both DAP kinase and Dlk, including mutant DC2, phosphorylate MLC in vitro and a recent report suggests that Dlk/ZIP kinase might be an authentic MLC kinase (MurataHori et al., 1999) . Interestingly, wild-type Dlk, when localized in the cytoplasm due to overexpression was not associated with actin ®laments nor was the nuclear transport-defective mutant RR406/407AL suggesting that in full length Dlk the binding domain for actin ®laments may be masked by the C-terminal tail. Under certain conditions, this binding domain may be released, either by posttranslational modification or by interaction with other proteins such as Par-4 (Page et al., 1999) . On the other hand, when the mutant DC2 was provided with a heterologous NLS from LT it was translocated to the nucleus with high eciency indicating that nuclear transport was dominant over association with actin ®laments, even in the mutant. Wild-type Dlk did not induce apoptosis to a signi®cant extent while the C-terminally truncated and hence cytoplasmic forms of Dlk were rather potent inducers of apoptosis. This proapoptotic activity was strictly dependent on the intrinsic kinase activity, on cytoplasmic localization and, presumably, on association with actin ®laments. At a ®rst glance, the apoptotic activity of mutant Dlk may be seen as an artefact. However, together with the ®ndings of Kawai et al. (1998) that (full length) ZIP kinase can induce apoptosis under certain experimental conditions one can assume: (i) that Dlk/ZIP kinase plays indeed a role in this process; and (ii) that Dlk needs to be activated to ful®ll this function. Activation could be achieved by dierent mechanisms, ®rst by posttranslational modi®cation such as phosphorylation. Dlk is subject to phosphorylation by other kinases (KH Scheidtmann, unpublished results) and undergoes extensive autophosphorylation. Second, by proteolytic processing. Speci®c cleavage in the C-terminal region could lead to cytoplasmic retention, binding to actin ®laments and activation of apoptotic activity, as mimicked by deletion mutants DC2 and DC3. This kind of activation has been described for protein kinases PKC d and MEKK1 both of which are activated by caspase cleavage (Emoto et al., 1995; Widmann et al., 1998) . Third, activation may occur by interaction with other proteins. One of the newly discovered interaction partners of Dlk is Par-4 which sensitizes cells for apoptosis (reviewed by Rangnekar, 1998) . Indeed, coexpression of Dlk with Par-4 leads to cytoplasmic retention of Dlk, association with actin ®laments and induction of apoptosis (see Page et al., 2000) . Thus, under certain conditions that need to be de®ned, Dlk may be retargeted to the cytoplasm to induce apoptosis.
What might be the function of nuclear Dlk/ZIP kinase? It is unlikely that it is only waiting there for apoptotic signals. It may function to maintain an antiapoptotic state, perhaps through interaction with and phosphorylation of components of PML bodies and other factors such as ATF-4. Based on these considerations Dlk/ZIP kinase might be envisaged as a molecular switch between proapoptotic and antiapoptotic pathways, its activity depending on its cellular localization which in turn might be regulated by various proapoptotic and antiapoptotic signals. Further experiments will reveal the actual biological function of Dlk/ZIP kinase.
Materials and methods
Cloning of Dlk fusion proteins
pEGFP-Dlk wt (codon 2 ± 448) was constructed as described previously (KoÈ gel et al., 1998) . For pEGFP-Dlk DC1 (codon 2 ± 417) the BamHI ± NheI fragment of pGEX-Dlk was ligated into pEGFP-C1 (Clontech, Palo Alto, CA, USA) digested with BglII and XbaI. pEGFP-Dlk DC2 (codon 1 ± 337) and pEGFP-Dlk DC3 (codon 1 ± 275) were generated using Pwo polymerase (Peqlab, Erlangen, Germany) to amplify subregions of full length Dlk. Primers were designed to contain a stop codon (reverse primer) and unique BglII and EcoRI sites that were ligated into pEGFP-C1. pEGFPDlk K42A was constructed by PCR mutagenesis with Pwo polymerase exchanging codon 42 from AAG (Lys) to GCC (Ala). For K42ADC2 and K42ADC3 the C-terminal BstXI ± SalI fragments of pEGFP-DlkDC2 and pEGFP-DlkDC3 were cloned into pEGFP-K42A digested with BstXI and SalI. Mutant DC2 LT-NLS was generated by fusing a double stranded oligonucleotide coding for the NLS of SV40 large T antigen (NH 2 -PKKKRKV-COOH) to the C-terminus of mutant pEGFP-Dlk DC2. pEGFP-Dlk N1 (codons 276 ± 448) was constructed by generating a PCR product¯anked by BamHI and BglII sites and cloning into pEGFP-C1 linearized by BamHI. For cloning of mutants RR341/342AA and RR406/407AL we employed the Altered Sites 2 in vitro Mutagenesis System (Promega, Madison, WI, USA). In RR341/342AA codons 341 and 342 (CGG and CGG) were substituted for GCC and GCC while in RR406/407AL codons 406 and 407 (CGT and CGC) were submitted for GCT and TTG. pKEX-HA-Dlk was constructed by fusing the HA epitope (NH 2 -MYPYDVPDYAEF-COOH) to the aminoterminus of the entire ORF of Dlk and cloning it into the SalI site of pKEX-2XR (Rittner et al., 1991) . All mutated constructs were con®rmed by restriction analysis and dideoxy sequencing with the T7 Sequencing 2 Kit (Pharmacia Biotec, Freiburg, Germany).
Cell culture and transfection
REF52.2 cells were cultured in Dulbecco's modi®ed Eagle's medium containing 10% fetal calf serum. They were seeded at 25 ± 30% con¯uence on 10 mm glass coverslips (for DAPI staining and immuno¯uorescence) or 60 mm cell culture dishes (for in vivo analysis of GFP fusion proteins) the day before transfection. Transient transfection was performed by lipofection with LipofectAmine 2 (Gibco ± BRL) in Opt-MEM (Gibco ± BRL, Paisley, UK) for 2 h after which the medium was exchanged and the cells were further incubated for 20 h. In the case of cells grown on coverslips 300 ng of plasmid DNA and 2 ml LipofectAmine were used for transfection while cells on 60 mm dishes were transfected with 3 mg of plasmid DNA and 20 ml LipofectAmine.
In vivo analysis of GFP fusion proteins
For in vivo analysis transfected REF52.2 cells were analysed as follows: the medium was removed from the cells and they were washed once in prewarmed PBS. After this the cells were overlayed with 3 ml of PBS and analysed bȳ uorescence microscopy with an Axiophot¯uorescence microscope from Zeiss equipped with a 406 objective.
Antibodies
The anti-PML monoclonal antibody 5E10 (Stuurmann et al., 1992) and monoclonal antibody anti-SC35 (Sigma, Deisenhofen, Germany) were kindly provided by Dr S Stamm (Max-Planck-Institute of Neurobiology, Munich, Germany). Polyclonal antibody anti-pol II and monoclonal antibody anti-PCNA were purchased from Santa Cruz Biotechnology (Heidelberg, Germany). Polyclonal antibody anti-U5-116 kD which is directed against a member of the snRNP family and stains splicing centers (Fabrizio et al., 1997) was a gift from Dr R LuÈ hrmann (Institute of Molecular Biology and Tumor Research, Marburg, Germany). Monoclonal antibody anti-HA was purchased from Roche Molecular Biochemicals, Mannheim, Germany. Secondary Cy 2 3-conjugated goat antimouse and goat anti-rabbit antibodies were from Dianova (Hamburg, Germany).
Immuno¯uorescence
For immuno¯uorescence with various antibodies directed against nuclear proteins or against the hemagglutinin-tag the transfected cells were ®rst washed three times in PBS and then ®xed in 2% paraformaldehyde in PBS for 15 min. After two additional washing steps in PBS the cells were permeabilized in 0.2% Triton X-100 in PBS. The cells were washed twice in PBS and subsequently blocked with 1% BSA in PBS for 30 min. Incubation with the primary antibodies was performed for 1 h at room temperature. After three washing steps in PBS the secondary antibody was added to a ®nal concentration of 1 mg/ml for 30 min at room temperature. The cells were washed three times in PBS and once brie¯y in H 2 O after which the coverslips were mounted in Perma¯uor mounting medium (Immunotech). Actin ®lament staining was performed according to Wulf et al. (1979) . After ®xation and blocking with BSA the cells were incubated with Tetramethylrhodamine B isothiocyanatephalloidin (0.5 mg/ml, Sigma) for 30 min at room temperature. Ensuing washes and mounting was performed as described above. The immunostained cells were subsequently examined with an Axiophot¯uorescence microscope (Zeiss) equipped with a 636 oil immersion objective.
Treatment with cytochalasin B
At 24 h posttransfection, cells were treated with cytochalasin B (Sigma) at 2.5 mg/ml for 15 min (modi®ed from Klotzsche et al., 1998) . Under these conditions half of the cells displayed disruption of the actin ®laments.
Evaluation of apoptosis
For comparative apoptosis studies cells were ®xed and permeabilized as described under immuno¯uorescence. DAPI (4,6-Diamidino-2-phenyindole) staining with a ®nal concentration of 1 mg/ml was performed for 15 min at room temperature. Final washing steps and mounting was performed as described for immuno¯uorescence. For calculation of speci®c apoptosis the transfected cells were scored for apoptotic morphology as judged by nuclear condensation, nuclear fragmentation and membrane blebbing.
